Capital expenditure · 2011–2025
Alnylam Pharmaceuticals capital expenditure
$58.7M+71.2% · FY2025
Alnylam Pharmaceuticals (ALNY) reported $58.7M in capital expenditure for fiscal 2025, +71.2% year on year.
| Fiscal year | Capital expenditure | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $58.7M | +71.2% | Open → |
| FY20242024-12-31 | $34.3M | −44.9% | Open → |
| FY20232023-12-31 | $62.2M | −13.7% | Open → |
| FY20222022-12-31 | $72.1M | −5.6% | Open → |
| FY20212021-12-31 | $76.4M | +8.5% | Open → |
| FY20202020-12-31 | $70.4M | −49.8% | Open → |
| FY20192019-12-31 | $140M | +10.5% | Open → |
| FY20182018-12-31 | $127M | +21.8% | Open → |
| FY20172017-12-31 | $104M | +61.4% | Open → |
| FY20162016-12-31 | $64.6M | +398.5% | Open → |
| FY20152015-12-31 | $13.0M | +44.5% | Open → |
| FY20142014-12-31 | $9.0M | +123.7% | Open → |
| FY20132013-12-31 | $4.0M | −52.0% | Open → |
| FY20122012-12-31 | $8.3M | +546.6% | Open → |
| FY20112011-12-31 | $1.3M | — | Open → |
Capital expenditure — Capital expenditure is the cash the company spent during the year on property, plant and equipment — factories, stores, servers, vehicles. It appears in the investing section of the cash-flow statement as an outflow and is shown here as a positive amount. Operating cash flow minus this figure is free cash flow.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +31.3%
Capital expenditure at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Alnylam Pharmaceuticals capital expenditure |url=https://companiesranked.com/en/company/alnylam-pharmaceuticals/capital-expenditure |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Alnylam Pharmaceuticals capital expenditure. CompaniesRanked. https://companiesranked.com/en/company/alnylam-pharmaceuticals/capital-expenditureBibTeX
@misc{companiesranked-en-company-alnylam-pharmaceuticals-capital-expenditure-2026,
author = {{CompaniesRanked}},
title = {{Alnylam Pharmaceuticals capital expenditure}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/alnylam-pharmaceuticals/capital-expenditure}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001628280-26-007497 · February 12, 2026
{{cite web |title=Alnylam Pharmaceuticals capital expenditure — 10-K (0001628280-26-007497) |url=https://www.sec.gov/Archives/edgar/data/1178670/000162828026007497/alny-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-12}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.